+91 789 2456 581 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
29 Nov 2014

Wintac Limited to divest oncology marketing division to BPRL

Bangalore-based Wintac Ltd has decided to sell its trademarks and marketing division for the oncology products to Bangalore Pharmaceuticals & Research Laboratory Pvt Ltd, in a related party transaction, for Rs 1.09 crore ($176,300), as per a stock market disclosure.

The divestment aims to completely focus on the core activity of product development and manufacturing business for the regulated export markets, it said.

Oncology division is a small part of the company which recorded a sales of Rs 2.01 crore during the financial year 2013-14. It contributed 6.48 per cent to the total sales turnover of the company.

Founded in 1990, Wintac, a pharmaceutical company, is engaged in manufacturing of small volume and large volume parental and sterile ophthalmic preparations. It develops products in the ophthalmic, injectables and critical care segments. The firm has its manufacturing facility at Nelamangala, Bangalore.

Ref: 1. http://www.vccircle.com/news/pharmaceuticals/2014/11/28/wintac-divest-oncology-marketing-division-promoter-group-firm

Leave a Reply

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests 

etc.